UK firms have been getting snapped up at a rate of knots recently. In the FTSE 250, we’ve seen Spirent Communications, the telecoms testing company, and cybersecurity firm Darktrace agree to be acquired. Currys and Direct Line have also attracted suitors. The reason, of course, is that many UK stocks ...
motleyfooluklse:docs
Shareholders in Dr Martens (LSE:DOCS), the iconic FTSE 250 bootmaker, have endured a torrid time lately. The value of their shares has more than halved since May 2023. And they’re now worth 80% less than the IPO price of 370p. Given that the company has issued five profit warnings since making its stock ...
motleyfooluklse:docs
Wow! Nobody saw that coming. The share price of Dr Martens (LSE:DOCS), the FTSE 250’s iconic fashion bootmaker, fell 28% during the week ended 19 April. The company warned that its profit before tax for the year ending 31 March 2025 (FY25) could be one third of its FY24 level. Not 33% lower, but 67% ...
motleyfooluklse:docs
Every month I invest in the stock market in a bid to increase my passive income. I try to find dividend shares that I think are well-placed to increase their payouts in the years ahead. Naturally, not all stocks I consider will win me over. Quite the opposite, in fact. Here are two dividend-paying UK ...
motleyfooluklse:docs
There’s a lot of interest in UK companies at the moment from a takeover perspective. And there’s a FTSE 250 company that I think might be a plausible acquisition target. Shares in Dr. Martens (LSE:DOCS) have fallen 79% since it initially appeared on the stock market in 2021. And it’s reached the point ...
motleyfoolukusx:decklse:docs
In his 2022 letter to Berkshire Hathaway shareholders, Warren Buffett praised share buybacks. He wrote: “Gains from value-accretive repurchases … benefit all owners — in every respect”. He went on: “When you are told that all repurchases are harmful to shareholders… you are listening to either an economic ...
motleyfooluklse:docs
